Advanced Triple Agonist Stack GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg

$308.00

This protocol combines Retatrutide, a triple-agonist targeting GLP-1, GIP, and glucagon receptors, with AOD-9604 and MOTS-c to create a comprehensive metabolic recomposition strategy.

  • Phorm Labs

SKU: ATGS Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Retatrutide drives the process by suppressing appetite, regulating blood sugar, and increasing thermogenesis from a systemic level, while AOD-9604 provides direct peripheral lipolysis by stimulating fat breakdown without affecting insulin or growth hormone levels.

Research Areas

  • Lipo3(Reta) 10mg
  • MOTS-c 10mg
  • AOD-9604 5mg

Additional information

Please Select

5mg, 10mg, 20mg

Reviews

There are no reviews yet.

Be the first to review “Advanced Triple Agonist Stack GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg”

Your email address will not be published. Required fields are marked *

Related products